490 filings
Page 12 of 25
4
Ian T Clark
23 Mar 20
Corvus Pharmaceuticals / IAN T CLARK ownership change
5:30pm
4
CRVS
Corvus Pharmaceuticals, Inc.
23 Mar 20
Corvus Pharmaceuticals / Steve E. Krognes ownership change
5:29pm
4
Morrison Scott W
23 Mar 20
Corvus Pharmaceuticals / Scott W Morrison ownership change
5:29pm
4
CRVS
Corvus Pharmaceuticals, Inc.
23 Mar 20
Corvus Pharmaceuticals / Peter A. Thompson ownership change
5:28pm
4
Gould Terry P
23 Mar 20
Corvus Pharmaceuticals / Terry P Gould ownership change
5:27pm
4
Adams Street Partners LLC
23 Mar 20
Change in insider ownership
4:03pm
8-K
CRVS
Corvus Pharmaceuticals, Inc.
20 Mar 20
Departure of Directors or Certain Officers
5:25pm
424B5
CRVS
Corvus Pharmaceuticals, Inc.
20 Mar 20
Prospectus supplement for primary offering
5:17pm
EFFECT
CRVS
Corvus Pharmaceuticals, Inc.
20 Mar 20
Notice of effectiveness
12:15am
CORRESP
CRVS
Corvus Pharmaceuticals, Inc.
17 Mar 20
Correspondence with SEC
12:00am
UPLOAD
CRVS
Corvus Pharmaceuticals, Inc.
12 Mar 20
Letter from SEC
12:00am
S-3
CRVS
Corvus Pharmaceuticals, Inc.
Shelf registration
9 Mar 20
5:12pm
10-K
2019 FY
CRVS
Corvus Pharmaceuticals, Inc.
Annual report
9 Mar 20
4:08pm
8-K
CRVS
Corvus Pharmaceuticals, Inc.
5 Mar 20
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
SC 13G/A
CRVS
Corvus Pharmaceuticals, Inc.
18 Feb 20
Beneficial ownership report (amended)
4:35pm
SC 13G/A
Biotechnology Value Fund L P
14 Feb 20
Corvus Pharmaceuticals, Inc.
2:52pm
SC 13G/A
T. Rowe Price Group Inc.
14 Feb 20
Corvus Pharmaceuticals, Inc.
1:30pm
8-K
CRVS
Corvus Pharmaceuticals, Inc.
13 Feb 20
Regulation FD Disclosure
8:00am
SC 13G/A
CRVS
Corvus Pharmaceuticals, Inc.
12 Feb 20
Beneficial ownership report (amended)
4:07pm
8-K
CRVS
Corvus Pharmaceuticals, Inc.
3 Feb 20
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum
8:00am